With the resurgence of illnesses, such as measles, it is of utmost importance that a high percentage of the local and global population be vaccinated. Diseases, such as measles, HepB, Hib, and others, are suppressed when 93%–95% of a population has been vaccinated against them, generating herd immunity. Lack of vaccination can lead to lifelong consequences. Barriers to vaccination include costs, lack of healthcare worker knowledge, reliance on cold chain storage, age, and personal beliefs. Vaccinations are usually administered as subcutaneous or intramuscular injections, though some oral vaccines exist. The use of intradermal or intramuscular electroporation (ID-EP and IM-EP) as an adjuvant has demonstrated benefits over traditional vaccination methods, while also having some issues, which require careful consideration. Issues for consideration include a lack of standardized equipment and pulsing protocols while benefits include dose sparing, long-term immunogenicity, and higher titer levels after a single dose compared to the gold standard. ID-EP has been shown to have better transfection rates over IM-EP, while IM-EP has demonstrated faster seroconversion rates (SRs) over IM injection alone. Improvements such as standardizing equipment with larger injection volumes, multiple EP site locations and/or disposable, predosed, lyophilized vaccine cartridges could contribute to more rapid deployment of vaccines without relying on cold chain storage and trained healthcare workers, at a reduced cost while still providing adequate levels of immunity against disease.
Ex-vivo liver perfusion (EVLP) is an ideal platform to study liver disease, therapeutic interventions, and pharmacokinetic properties of drugs without any patient risk. Rat livers are an ideal model for EVLP due to less organ quality variability, ease of hepatectomy, well-defined molecular pathways, and relatively low costs compared to large animal or human perfusions. However, the major limitation with rat liver normothermic machine perfusion (NMP) is maintaining physiologic liver function on an ex-vivo machine perfusion system. To address this need, our research demonstrates 24-hour EVLP in rats under normothermic conditions. Early (6 hour) perfusate transaminase levels and oxygen consumption of the liver graft are shown to be good markers of perfusion success and correlate with viable 24-hour post-perfusion histology. Finally, we address overcoming challenges in long-term rat liver perfusions such as rising intrahepatic pressures and contamination, and offer future directions necessary to build upon our work.
In vitro tools, which can enable development of models that replicate the cell microenvironment associated with complex diseases such as osteoarthritis (OA), are critically needed. In OA, catabolic and inflammatory processes orchestrated by multiple cell types lead to the eventual destruction of articular cartilage. To address this need, our group developed a device that will enable investigation of complex cell systems. Our stackable tissue culture insert was fabricated and characterized with respect to biocompatibility, ease of use, and potential for tissue culture applications. The stackable tissue culture inserts can be easily modified, fabricated, and assembled into commercially available multi-well plates. In vitro studies conducted with three different cell types demonstrated high cell viability and functional secretion when cultured in the stackable inserts. Furthermore, synergistic effects when the three cell types were cultured together were observed. This demonstrates the need to more fully interrogate in vitro culture systems, and this stackable insert can provide a tool to fill the current technological void to do so.
Pulsed electric field (PEF) is an emerging technology for biomass processing and fractionation by electroporation of cell membrane. Nevertheless, PEF technology and devices require tailoring and adaptation for each specific type of biomass. Such an optimization requires convenient and adaptable laboratory systems, which will enable both electrical and mechanical parameters determination before process upscaling. In this work, we report on the design and development of a laboratory PEF system that allows applying for up to 4[Formula: see text]kV, 1[Formula: see text]kA pulses with 1–100[Formula: see text][Formula: see text]s and total power dissipation of 20[Formula: see text]W and up to 25[Formula: see text]kg of mechanical load. The design of an asymmetric voltage multiplying circuit allows for controlling pulse parameters for each pulse in series. Such an approach enables precise adaptation of PEF to the changing conductivity of the biomass, minimizing the total invested energy in the process. The system was tested on highly conductive marine macroalgae Ulva sp, a promising but challenging feedstock for the biorefinery. This work provides a design of an adaptable PEF device, important for biomass processing with electroporation.
Microfluidic devices are constructed from polydimethylsiloxane (PDMS) due to their biocompatibility, fabrication ease, well-established protocols, and simplicity. PDMS-based microfluidic devices are constructed by (i) applying liquid PDMS to a negative mold (usually a silicon or 3D-printed mold) and (ii) curing the PDMS with heat exposure over a set time period. Unreacted resin monomers in 3D-printed molds prevent PDMS from fully curing, resulting in improper channel formation in PDMS and reducing the PDMS device’s efficacy. An in-house protocol that uses SU-8 as a “non-stick” coating on 3D-printed molds facilitates the successful casting of PDMS. Contact angle, surface profile, optical profile, and force testing prove that PDMS cast from SU-8-treated molds resembles pristine PDMS, unlike PDMS cast from untreated molds. Further, this method is generalized to commercial 3D prints using different 3D printing resins. To demonstrate this technique’s viability in microfluidic devices, a microfluidic tree using PDMS from treated 3D prints shows vibrant colors and clear lines. This is absent from an untreated PDMS.
Cutaneous wound healing is a highly coordinated process involving numerous molecular pathways that regulate the function of specific skin cell types. One of the key decisions in acute and/or chronic wound healing management is to choose the skin substitute that, based on its composition and/or properties, may act as permanent skin replacement or temporary wound cover. The current products however are limited in their action, especially in the context of large chronic wounds or extensive second-/third-degree burns, due to the risk of developing infection, the limited vascularization, the inability to integrate to host tissue, and the lack in the healed area of skin apparatus responsible for temperature control, pigmentation, immune regulation, and nerve supply. In addition, the high cost of skin substitutes precludes their use in small- and moderate-size burns because they are economically impractical and protract the time to definitive wound closure. Thus, the need to develop cost-effective substitutes of high quality is imperative. The purpose of this review is to discuss current available products, their limitations and to provide some perspectives on future research toward generation of cost-effective, high-quality substitutes.
Engineered liver grafts for transplantation with sufficient hepatic function have been developed both in small and large animal models using the whole liver engineering approach. However, repopulation of the bile ducts in the whole liver scaffolds has not been addressed yet. In this study, we show the feasibility of repopulating the bile ducts in decellularized rat livers. Biliary epithelial cells were introduced into the bile ducts of the decellularized liver scaffolds with or without hepatocytes in the parenchymal space. The recellularized grafts were cultured under perfusion for up to 2 days and histological analysis revealed that the biliary epithelial cells formed duct-like structures, with the viable hepatocyte mass residing in the parenchymal space, in an arrangement highly comparable to the native tissue. The grafts were viable and functional as confirmed by both albumin and urea assay results and the gene expression analysis of biliary epithelial cells in recellularized liver grafts. This study provides the proof-of-concept results for rat liver grafts co-populated with parenchymal and biliary epithelial cells.
Neural activity that occur during motor movement, speech, thought, and various other events can be observed in the form of brainwaves composed of synchronized electrical pulses emitted from adjoining communicative neurons. Observations of these brainwaves have been made possible through neurodevices, which can detect changes in electrical and/or mechanical parameters. For decades, the field of neuroscience has been enriched by the utilization of neurotechnologies at the microscale, which has begun to gain further enhancement with the introduction of nanotechnology. For example, microelectrodes were initially used for only extracellular measurements, but over the past decade, developments have been made to also record intracellular signals. Likewise, nanoknives, which gained popularity due to their versatility, can now be used for both fabricating bio-Micro-Electro-Mechanical Systems (MEMS) and also as a neurosurgery tool. Thus, considerable efforts have been made over the years to make micro- and nanosystems reliable, accurate, and sensitive to neural activity. In the late 20th century, several sophisticated technologies, including magnetic resonance imaging (MRI), computed tomography (CT), and intracranial pressure (ICP) monitoring have been integrated with MEMS. Furthermore, existing biotechnologies are being miniaturized at both the system and component level. For example, there is a remarkable interest in the field of neuroscience to utilize microfluidic technology as a diagnostic tool using specimens such as cerebrospinal fluid (CSF). Microfluidic devices are also employed as biocompatible drug delivery systems to target cells, tissues, and organs. This paper summarizes the recent developments in micro- and nano-scale neurotechnologies, including devices, fabrication processes, detection methods, their implementation challenges, in neural stimulation, monitoring, and drug delivery. This review discusses recent developments in micro and nanotechnologies, fabrication methods, and their implementation in neuroimaging, neurostimulation, monitoring of neural activities, and neural drug delivery.
Due to the growth of cell-based therapeutic alternatives addressing the shortage of livers for transplant, there is necessity for a reliable source of human hepatocytes. In addition, pharmaceutical research often requires human hepatocytes to assess new drug therapies during development or to achieve FDA approval. Whole human livers producing large quantities of cells from the same donor are ideal, enhancing reproducibility for all purposes, while also allowing for capturing variances in drug-metabolism across different demographics for pharmaceutical testing and development but are limited in availability and quality for research purposes. The present study investigates the effect of donor and liver procurement factors of 16 human livers on cell viability and yield, showing that typical exclusion criteria for transplant still produce viable hepatocytes with significant yields. Although limited in number of data points, which should be taken into consideration, the conclusions of this study could be utilized as indications, allowing for expansion of liver selection criteria for hepatocyte isolation and provide the necessary quality hepatocytes in large quantities for the growing pharmaceutical, biomedical, and therapeutic research fields.
Chronic skin wounds are hypoxic and are stalled in a pro-inflammatory state. Hemoglobin (Hb)-based oxygen carriers have shown potential in increasing oxygen delivery to aid wound healing. Macrophages also take up Hb, thus altering their phenotype and the regulation of inflammation. Herein, we compared the effect of Hb and polymerized Hbs (PolyHbs) on the phenotype of human macrophages. Macrophages were incubated with Hb or different forms of PolyHbs, and the inflammatory secretion profile was analyzed. PolyHbs were produced by polymerizing Hb in the relaxed (R) or tense (T) quaternary state and by varying the molar ratio of the glutaraldehyde crosslinking agent to Hb. Hb decreased the secretion of most measured factors. PolyHb treatment led to generally similar secretion profiles; however, Hb had more similar trends to R-state PolyHb. Ingenuity pathway analysis predicted positive outcomes in wound healing and angiogenesis for T-state PolyHb prepared with a 30:1 (glutaraldehyde:Hb) polymerization ratio. When tested in diabetic mouse wounds, T-state PolyHb resulted in the greatest epidermal thickness and vascular endothelial CD31 staining. Thus, the effects of PolyHb on macrophages are affected by the polymerization ratio and the quaternary state, and T-state PolyHb yields secretion profiles that are most beneficial in wound healing.
Obtaining venous access for blood sampling or intravenous (IV) fluid delivery is an essential first step in patient care. However, success rates rely heavily on clinician experience and patient physiology. Difficulties in obtaining venous access result in missed sticks and injury to patients, and typically require alternative access pathways and additional personnel that lengthen procedure times, thereby creating unnecessary costs to healthcare facilities. Here, we present the first-in-human assessment of an automated robotic venipuncture device designed to safely perform blood draws on peripheral forearm veins. The device combines ultrasound imaging and miniaturized robotics to identify suitable vessels for cannulation and robotically guide an attached needle toward the lumen center. The device demonstrated results comparable to or exceeding that of clinical standards, with a success rate of 87% on all participants (n = 31), a 97% success rate on nondifficult venous access participants (n = 25), and an average procedure time of 93 ± 30 s (n = 31). In the future, this device can be extended to other areas of vascular access such as IV catheterization, central venous access, dialysis, and arterial line placement.
Here we present a model to estimate the interaction free energy contribution of each amino acid residue of a given protein. Protein interaction energy is described in terms of per-residue interaction factors, μ. Multibody interactions are implicitly captured in μ through the combination of amino acid terms (γ) guided by local conformation indices (σ). The model enables construction of an interaction factor heat map for a protein in a given fold, allows prima facie assessment of the degree of residue-residue interaction, and facilitates a qualitative and quantitative evaluation of protein association properties. The model was used to compute thermal stability of T4 bacteriophage lysozyme mutants across seven sites. Qualitative assessment of mutational effects provides a straightforward rationale regarding whether a particular site primarily perturbs native or non-native states, or both. The presented model was found to be in good agreement with experimental mutational data (R 2 = 0.73) and suggests an approach by which to convert structure space into energy space.
Platelets are blood components with high biomedical potential due to their physiological role in wound healing and their rich growth factor content. This paper describes proof of concept experiments aimed to produce a new blood derived product by applying Pulsed Electric Fields (PEF) in platelet concentrates with no therapeutic value for transfusion medicine. A human platelet concentrate suspension was subjected to a PEF treatment of 1 pulse, 5 kV/cm, with 2 μs. Release of Platelet Derived Growth Factor (PDGF) from the electroporated platelets was measured by ELISA. Furthermore, the biological activity of the obtained blood derived product was characterized. Human mesenchymal stem cells (hMSC) were cultured in the presence of the proteins released from the platelets after PEF application and evaluated for their expansion potential.Results show that platelets concentrates submitted to a single PEF treatment can release PDGF to the supernatant. Protein release from the single and transient PEF cycle was confirmed by the expansion of hMSC cultured with a medium supplemented with platelet releasate obtained from electroporated platelets. These results support the valorization of platelet concentrates with no transfusion value that would otherwise be discarded. Applying PEF might allow the development of alternative releasate for different biomedical applications, namely stem cells culture.
Flow cytometry is an invaluable tool utilized in modern biomedical research and clinical applications requiring high throughput, high resolution particle analysis for cytometric characterization and/or sorting of cells and particles as well as for analyzing results from immunocytometric assays. In recent years, research has focused on developing microfluidic flow cytometers with the motivation of creating smaller, less expensive, simpler, and more autonomous alternatives to conventional flow cytometers. These devices could ideally be highly portable, easy to operate without extensive user training, and utilized for research purposes and/or point-of-care diagnostics especially in limited resource facilities or locations requiring on-site analyses. However, designing a device that fulfills the criteria of high throughput analysis, automation and portability, while not sacrificing performance is not a trivial matter. This review intends to present the current state of the field and provide considerations for further improvement by focusing on the key design components of microfluidic flow cytometers. The recent innovations in particle focusing and detection strategies are detailed and compared. This review outlines performance matrix parameters of flow cytometers that are interdependent with each other, suggesting trade offs in selection based on the requirements of the applications. The ongoing contribution of microfluidics demonstrates that it is a viable technology to advance the current state of flow cytometry and develop automated, easy to operate and cost-effective flow cytometers.
Cancer is a devastating disease that takes the lives of hundreds of thousands of people every year. Due to disease heterogeneity, standard treatments, such as chemotherapy or radiation, are effective in only a subset of the patient population. Tumors can have different underlying genetic causes and may express different proteins in one patient versus another. This inherent variability of cancer lends itself to the growing field of precision and personalized medicine (PPM). There are many ongoing efforts to acquire PPM data in order to characterize molecular differences between tumors. Some PPM products are already available to link these differences to an effective drug. It is clear that PPM cancer treatments can result in immense patient benefits, and companies and regulatory agencies have begun to recognize this. However, broader changes to the healthcare and insurance systems must be addressed if PPM is to become part of standard cancer care.
Diagnostic blood testing is the most commonly performed clinical procedure in the world, and influences the majority of medical decisions made in hospital and laboratory settings. However, manual blood draw success rates are dependent on clinician skill and patient physiology, and results are generated almost exclusively in centralized labs from large-volume samples using labor-intensive analytical techniques. This paper presents a medical device that enables end-to-end blood testing by performing blood draws and providing diagnostic results in a fully automated fashion at the point-of-care. The system couples an image-guided venipuncture robot, developed to address the challenges of routine venous access, with a centrifuge-based blood analyzer to obtain quantitative measurements of hematology. We first demonstrate a white blood cell assay on the analyzer, using a blood mimicking fluid spiked with fluorescent microbeads, where the area of the packed bead layer is correlated with the bead concentration. Next we perform experiments to evaluate the pumping efficiency of the sample handling module. Finally, studies are conducted on the integrated device - from blood draw to analysis - using blood vessel phantoms to assess the accuracy and repeatability of the resulting white blood cell assay.
The pollen tube is a tip growing cell that is able to invade plant tissues in order to accomplish its function - the delivery of sperm cells to the ovule. The pistillar tissues through which the tube has to elongate represent a formidable mechanical obstacle, but it is unknown how much force the growing tube is able to exert, or how mechanical impedance affects its growth behavior. We quantified the invasive force of individual pollen tubes using a microfluidic lab-on-a-chip device featuring a microscopic cantilever. Using finite element method the maximum invasive growth force of the growing pollen tube was determined to be in the microNewton range. Real time monitoring revealed that contact with the mechanical obstacle caused a shift in the peak frequency characterizing the oscillatory behavior of the pollen tube growth rate. This suggests the presence of a feedback-based control mechanism with a mechanical regulatory component.
A scale-up nanoporous membrane centrifuge is designed and modeled. It can be used for nanoscale scale separation including reverse osmosis desalination. There are micron-size pores on the wall of the centrifuge and nanoscale pores on local graphene membrane patches that cover the micron-size pores. In this work, we derived the critical angular velocity required to counter-balance osmosis force, so that the reverse-osmosis (RO) desalination process can proceed. To validate this result, we conducted a large scale (four million atoms) full atom molecular dynamics (MD) simulation to examine the critical angular velocity required for reverse osmosis at nanoscale. It is shown that the analytical results derived based on fluid mechanics and the simulation results observed in MD simulation are consistent and well matched. The main advantage of such nanomaterial based centrifuge is its intrinsic anti-fouling ability to clear [Formula: see text] and [Formula: see text] ions accumulated at the vicinity of the pores due to the Coriolis effect. Analyses have been conducted to study the relation between osmotic pressure, centrifugal pressure, and water permeability.
Based on the insight that only living organisms can be killed (and that killing can proceed much faster than cell-growth), we present an approach for the detection of viable microorganisms that is much faster than currently used culture-based methods. We do so by using microchannel Electrical Impedance Spectroscopy (m-EIS) for real-time detection of cell-death on exposure to a killing-agent. m-EIS relies on the fact that when living-cells with non-zero membrane potentials are exposed to high-frequency AC-field, induced-charges accumulate at the membrane-interface. Cell-death is accompanied by a loss of membrane-potential, and hence charge-storage (capacitance). A proof-of-principle for a clinical-application (detection of living mycobacteria in sputum) is demonstrated. Mycobacterium smegmatis (doubling-time ∼3 hours) and Mycobacterium bovis BCG (doubling-time ∼20 hours) in artificial-sputum are both detected in [Formula: see text]3 hours when exposed to amikacin. Times-to-detection (TTDs) are ∼12 hours and ∼84 hours (3 1/2 days), respectively for culture-based detection using current technologies (BD-MGIT-960[Formula: see text]) for samples containing similar loads of M. smegmatis and M. bovis BCG
Whole organ engineering has emerged as a promising alternative avenue to fill the gap of donor organ shortage in organ transplantation. Recent breakthroughs in the decellularization of solid organs and repopulation with desired cell populations have generated neo-organ constructs with promising functional outcomes. The realization of this goal requires engineering advancement in the perfusion-based bioreactors to (i) efficiently deliver decellularization agents, followed by (ii) its reconstruction with relevant cell types and (iii) maintenance of viability and function of the repopulated organ. In this study, we report the development and assembly of a perfusion bioreactor with the potential to enable regenerative reconstruction of pancreas. The assembled bioreactor is versatile to efficiently decellularize multiple organs, as demonstrated by complete decellularization of pancreas, liver and heart in the same set-up. Further, the same system is amenable to support organ repopulation with diverse cell types. Using our in-house bioreactor system, we demonstrate pancreas repopulation with both immortalized MIN-6 beta cells and differentiating human pluripotent stem cells. Importantly, we show the significant advantage of perfusion culture over static culture in enhancing cell engraftment, viability and phenotypic maintenance of the repopulated pancreas. In addition, this study is a significant step forward for whole organ engineering as it will facilitate cost-effective and easy assembly of perfusion bioreactors to enable rapid advancement in regenerative organ reconstruction.
